Abstract Somatic mutations in Ras proto-oncogenes have been found in a large number of different cancers. In addition, germline mutations in the H-Ras gene have been shown to be the causative genetic alteration underlying Costello Syndrome (CS). Costello Syndrome belongs to the large group of Ras/MAPK pathway diseases commonly termed Rasopathies. CS patients exhibit craniofacial and cardiac abnormalities, mental retardation and are prone to develop cancers including neural crest derived neoplasias. Since Costello Syndrome is a rare disease, the effects of H-RasG12V expression on the development of the central nervous system remain largely uncharacterized. Towards this goal, we have established a zebrafish model suitable for live imaging and cost-effective drug screening. Using the Gal4/UAS system we have enforced expression of H-RasG12V in the central nervous system starting at early neurulation stages. H-RasG12V expressing embryos develop hyperplasia of the forebrain and the spinal cord and show an outgrowth in the dorsal tail region around 3 days post fertilization (dpf). In situ hybridisation revealed an increase in oligodendrocyte precursor cells, similar to what has been reported for zebrafish neurofibromin 1 mutants. In addition, cells expressing the neural crest markers Sox10 and FoxD3 accumulate lateral to the neural tube and notochord. Time-lapse imaging revealed that H-RasG12V expressing cells indeed migrate out of the spinal cord. This migration was ectopic, occuring several hours after normal neural crest migration. Furthermore, coinciding with the accumulation of neural crest like cells around the neural tube, the intersomitic vasculature hyperbranches to form new blood vessels towards domains of H-RasG12V expressing cells. Taking advantage of the early onset and obvious phenotypes in our H-RasG12V overexpression model we performed a pilot drug screen to identify potential therapeutic compounds for Costello Syndrome. We found the Mek1/Mek2 inhibitor PD98059 successfully inhibited hyperplasia of the forebrain and the spinal cord, with normal numbers of oligodendrocyte precursor cells and neural crest cells. Thus, this zebrafish model will be a valuable tool to further investigate the mechanisms underlying CNS- abnormalities of Costello Syndrome patients, including the formation of neural crest derived neoplasias and will be useful to identify therapies against this disease. This abstract is also presented as Poster A3. Citation Format: Martin Distel, David Traver. H-RasG12V overexpression in the central nervous system leads to expansion of oligodendrocyte precursor cells and neural crest cells. [abstract]. In: Proceedings of the AACR Special Conference on Pediatric Cancer at the Crossroads: Translating Discovery into Improved Outcomes; Nov 3-6, 2013; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2013;74(20 Suppl):Abstract nr PR01.
Read full abstract